Classification of firearm wounds management of gun shot injury from front of chest

Reading File

Now let me search the medical library and PubMed in parallel for comprehensive coverage.

Finding Sources

Searching PubMed

"gunshot wound" AND "chest" AND management

Good - found relevant files. Let me read those sections and search for more specific content in parallel.

Reading File

Finding Sources

Excellent - found very relevant sections. Let me read those in parallel.

Reading File

Finding Sources

Let me now get the core thoracic trauma section from Mulholland and the Schwartz chest injuries section.

Reading File

Finding Sources

Let me now get the Schwartz chest injuries section and the open pneumothorax content, plus the emergency thoracotomy indications.

Reading File

Finding Sources

Now let me get the Bailey & Love section on pericardial tamponade and the Current Surgical Therapy overview on penetrating chest wounds, plus the Schwartz chest injuries section.

Reading File

Let me get the EDRT section content and the Schwartz chest injuries section for thoracotomy indications.

Reading File

I now have very comprehensive information from multiple authoritative textbooks. Let me compile the complete answer.

Classification of Firearm Wounds and Management of Gunshot Injury to the Front of the Chest

I. Classification of Firearm (Gunshot) Wounds

A. By Wound Morphology

1. Entry Wound

Typically smaller, round/oval with inverted (indrawn) edges
Surrounded by an abrasion collar (zone of contusion/friction from bullet spin)
Edges relatively clean and regular
May have tattooing (stippling) from unburnt gunpowder in close-range shots
Burn/blackening/singed hair in contact/near-contact wounds

2. Exit Wound

Usually larger, irregular, stellate or cruciate, with everted (outturned) edges
No abrasion collar
More tissue destruction
Note: Exit wound may be absent if bullet is retained (low-velocity, dissipated energy)

3. Graze/Tangential Wound

Bullet skims across surface without full penetration
Elongated, boat-shaped trough
Beveled edges

B. By Range of Fire

Range	Features
Contact	Muzzle placed against skin; star-shaped laceration; blackening, burning, carbon tattooing inside wound
Close range (<60 cm)	Gunpowder tattooing/stippling on skin; singeing
Intermediate (60 cm - 1 m)	Some tattooing but no burning
Distant (>1 m)	Neat entry wound, abrasion collar only; no tattooing

C. By Ballistic Type (Weapon/Bullet Velocity)

1. Low-velocity wounds (<600 m/s - handguns, shotguns at distance)

Bullet causes damage primarily by laceration and crushing along its path
Relatively limited tissue destruction
Wound track = caliber of bullet

2. High-velocity wounds (>600 m/s - military rifles, assault weapons)

Significant cavitation effect: temporary cavity much larger than bullet (up to 30x diameter)
Massive tissue destruction beyond the wound track
Yaw and tumbling: bullet becomes unstable inside tissue - greatly increases tissue damage
Fragmentation possible
Entry wound often deceptively small compared to internal damage

3. Shotgun wounds

Contact/close range: devastating single large wound, wad/pellets + powder inside wound
Intermediate: pellets begin to scatter, multiple puncture wounds
Distant: diffuse pellet pattern, each wound individually minor

D. By Depth of Penetration

Perforating - bullet enters AND exits (both entry + exit wound present)
Penetrating - bullet enters and is retained within body (entry wound only)
Avulsive/Tangential - bullet grazes surface without full penetration

II. Injuries Caused by Gunshot to the Front of the Chest

The anterior chest is bordered by the sternum, ribs, and chest wall musculature. The key structures at risk include:

Zone	Structures at Risk
Cardiac box (sternal notch to xiphoid, nipple-to-nipple)	Heart, great vessels, trachea, esophagus
Right hemithorax	Right lung, right hilum, liver (low), IVC
Left hemithorax	Left lung, left hilum, heart, aorta
Upper chest	Trachea, subclavian vessels, brachial plexus
Thoracoabdominal (below 4th ICS anteriorly)	Diaphragm, liver, spleen, stomach

Important: The diaphragm may rise as high as the 4th intercostal space anteriorly during expiration - so wounds at or below the nipple line may involve abdominal organs. Coincident thoracic penetration occurs in up to 46% of patients with abdominal injuries.

III. Specific Injury Patterns and Management

1. Simple/Tension Pneumothorax

Pathophysiology: Air enters pleural space from lung or chest wall defect, collapses ipsilateral lung. Tension pneumothorax develops when a one-way valve mechanism traps air - pressure builds, collapses lung, shifts mediastinum, compresses vena cava - causing obstructive shock.

Clinical features (Tension PTX):

Respiratory distress, hypoxia, tachypnea
Absent unilateral breath sounds + hyperresonance
Tracheal deviation away from affected side
Distended neck veins, hypotension, tachycardia
Differentiate from tamponade: tamponade has muffled heart sounds, NO tracheal deviation

Management:

Tension PTX = clinical emergency, do NOT wait for CXR
Immediate needle decompression: 2nd intercostal space, midclavicular line (or 5th ICS, anterior axillary line in obese)
Followed by chest tube (intercostal drain) in the 4th-5th ICS, anterior axillary line ("safe triangle")
Simple PTX: chest tube only; occult PTX (CT only, no CXR finding) may be observed if patient is stable and not on positive pressure ventilation

2. Open Pneumothorax (Sucking Chest Wound)

Occurs when the chest wall defect exceeds the laryngeal cross-sectional area (typically large-caliber gunshot wounds). Air rushes in from outside with each breath - lung collapses, mediastinal shift, decreased venous return.

Signs: Visible wound with sucking/bubbling sound on respiration, hypoxia, respiratory failure.

Management (Current Surgical Therapy, 14e):

Apply three-sided occlusive dressing (allows air egress but prevents inflow) - Asherman chest seal or petroleum gauze
Insert a chest tube remote from the wound - BEFORE closing the defect (to prevent converting to tension PTX)
Wound debridement and formal surgical closure once the patient is stable

3. Hemothorax

Definition: Blood in the pleural space. Most common injury after both penetrating and blunt thoracic trauma.

Classification by volume:

Small: <300 mL
Moderate: 300-1500 mL
Massive: >1500 mL (immediately life-threatening)

Management:

>85% of cases can be definitively managed with chest tube alone (28-32 Fr intercostal drain, 4th-5th ICS, anterior axillary line) - Schwartz's Principles of Surgery, 11e
Emergency Department Thoracotomy / Surgical indications:
- Initial chest tube output >1500 mL (20% estimated blood volume in children)
- Ongoing output >150-200 mL/hr for 4 hours (or 2-3 mL/kg/hr in children)
- Hemodynamic instability not responding to resuscitation
- Patient physiology should guide surgical decision over absolute blood volumes
Retained hemothorax: Video-assisted thoracoscopic surgery (VATS) preferred in stable patients

4. Cardiac Tamponade

Caused by penetrating injury to the heart (especially wounds in the "cardiac box"). As little as 50 mL of blood in the non-distensible pericardial sac compresses the heart and obstructs venous return.

Classic Beck's Triad:

Elevated CVP / distended neck veins
Hypotension + tachycardia
Muffled heart sounds

Note: Neck veins may be flat if concurrent major blood loss has occurred.

Diagnosis: eFAST (most expeditious and reliable - fluid in pericardial sac)

Management (Bailey & Love, 28e):

Pericardiocentesis has NO role in penetrating cardiac tamponade (clot prevents aspiration)
Correct treatment is operative:
- Subxiphoid pericardial window (if patient is relatively stable)
- OR left anterolateral thoracotomy / sternotomy for direct cardiac repair
- If in ED with witnessed cardiac arrest from penetrating chest injury: Emergency Department Resuscitative Thoracotomy (EDRT)

5. Emergency Department Resuscitative Thoracotomy (EDRT)

Indicated for patients in extremis from penetrating chest wounds. Decision guided by EAST Practice Management Guidelines:

Signs of Life in ED	Mechanism	Location	Recommendation
Yes	Penetrating	Thoracic	Strongly yes
Yes	Penetrating	Non-thoracic	Yes
No (witnessed arrest)	Penetrating	Thoracic	Yes
No (unwitnessed)	Blunt	Any	Not recommended

Best survival (~35%): Single penetrating stab wound to cardiac box + tamponade on FAST + witnessed arrest in ED. Gunshot wounds have lower survival than stab wounds in EDRT. Blunt arrest has near-zero survival.

Technique: Left anterolateral thoracotomy - pericardium opened, clot evacuated, cardiac laceration repaired (digital pressure, Satinsky clamp for atrial wounds; skin staples or Foley catheter balloon for temporary ventricular occlusion; definitive repair with pledgeted non-absorbable sutures).

6. Pulmonary Parenchymal Injury

Most are managed with tube thoracostomy alone
Persistent air leak: bronchoscopy-directed fibrin glue or VATS
Central injuries during thoracotomy: pulmonary tractotomy (GIA stapler inserted into injury track, filleted open, individual vessels and bronchi ligated) - avoids formal lobectomy
Peripheral lacerations: stapled wedge resection
Formal lobectomy only for proximal vascular/bronchial injury found on tractotomy
Pneumonectomy is almost always fatal due to right heart decompensation

7. Tracheobronchial Injury

Signs: air escaping from neck wound, massive air leak post-chest tube, hemoptysis, stridor, subcutaneous emphysema.

Management:

Pass ETT beyond the injury or into contralateral mainstem bronchus for ventilation
Primary end-to-end repair (3-0 PDS, single layer interrupted)
Suture line buttressed with vascularized tissue (pericardium, intercostal muscle, pleura)
Bronchial injuries <1/3 circumference with no major air leak: expectant management

8. Thoracoabdominal Wounds (Below 4th ICS Anteriorly)

Must exclude diaphragmatic injury (diaphragm rises to 4th ICS anteriorly in expiration)
Diaphragmatic wounds may not be apparent initially - diagnose by laparoscopy
All injuries to the diaphragm require repair (staple/suture)
Must also assess for injury to liver, spleen, stomach

IV. ATLS Primary Survey Framework for Penetrating Chest GSW

"MARCH" / "ABCDE" priorities:

A - Airway: Secure; cricothyroidotomy if cannot intubate
B - Breathing: Identify/treat tension PTX, open PTX, hemothorax, flail chest
C - Circulation: FAST for tamponade; control hemorrhage; IV access; permissive hypotension (target SBP 80-90 mmHg in penetrating torso trauma) until surgical hemorrhage control - AVOID fluid overload
D - Disability: GCS, pupils
E - Exposure: Full exposure, look for exit wound, thoracoabdominal involvement

Key principle in penetrating chest GSW: Avoid extensive pre-hospital interventions - rapid transport to trauma centre takes priority. Hypotensive resuscitation (limited resuscitation before operative hemorrhage control) is now the military-derived standard for civilian penetrating torso trauma.

Sources: Current Surgical Therapy 14e; Bailey & Love's Short Practice of Surgery 28e; Schwartz's Principles of Surgery 11e; Mulholland and Greenfield's Surgery 7e

Classification of firearm wounds management of gun shot injury from front of chest

Reading File

Searching the library with parallel queries now.

Finding Sources

Good - I have the key file paths. Now reading all the key sections in parallel.

Reading File

Finding Sources

Excellent data collected. Now reading the EDRT section and the Schwartz thoracotomy indications table, plus the open pneumothorax section.

Reading File

Finding Sources

I now have comprehensive, authoritative content from multiple surgical textbooks. Let me fetch the needle decompression image and the cardiac repair image to include visually, and also get the EAST guideline table.

Reading File

Loading Image

I now have all the content and images needed for a comprehensive, well-illustrated answer. Let me compile the full response.

Classification of Firearm Wounds and Management of Gunshot Injury to the Front of the Chest

PART 1: CLASSIFICATION OF FIREARM WOUNDS

A. Classification by Wound Morphology

1. Entry Wound

Typically smaller, round or oval with inverted (indrawn) edges
Has an abrasion collar (graze contusion ring) - caused by bullet spin and friction against skin
Central defect = approximately bullet caliber
Surrounding skin intact / relatively clean edges
At contact range: star-shaped laceration from gas blast, blackening, burning, carbon tattooing inside the wound canal
At close range (<60 cm): gunpowder stippling/tattooing on skin, possible singeing

2. Exit Wound

Usually larger, irregular, stellate or cruciate shape
Edges are everted (outturned)
No abrasion collar
Greater tissue destruction
May be absent if bullet is retained (low-velocity, energy dissipated, or bullet fragmented)

3. Tangential / Graze Wound

Bullet skims the surface without full penetration
Elongated, boat-shaped trough with beveled edges
Both ends have features of entry (abrasion collar at entry end)

B. Classification by Range of Fire

Range	Wound Features
Contact (muzzle touches skin)	Star-shaped laceration; burning, blackening, carbon tattooing inside wound; muzzle imprint on skin
Close range (<60 cm)	Gunpowder stippling/tattooing on surrounding skin; singeing of hair
Intermediate (60 cm - 1 m)	Faint tattooing present; no burning
Distant (>1 m)	Clean entry wound with abrasion collar only; no tattooing

C. Classification by Ballistic Type (Velocity)

1. Low-Velocity Wounds (<600 m/s - handguns, pistols)

Damage by laceration and crushing along bullet track
Wound track = approximately bullet caliber
Relatively limited tissue destruction beyond direct path
Bullet often retained (penetrating, no exit wound)

2. High-Velocity Wounds (>600 m/s - military rifles, assault weapons)

Cavitation effect: temporary cavity forms that is up to 30x the bullet diameter - massive tissue destruction well beyond the bullet track
Yaw and tumbling: bullet becomes unstable inside tissue, dramatically increasing damage
Entry wound is deceptively small compared to internal destruction
Fragmentation possible - multiple secondary missiles
Exit wound is large and irregular

3. Shotgun Wounds

Distance	Pattern
Contact/Close	Single devastating wound; wad + pellets + powder may be inside
Intermediate	Pellets scatter - multiple puncture wounds
Distant	Diffuse pellet pattern; individual wounds minor; pattern useful for range estimation

D. Classification by Depth of Penetration

Perforating wound - bullet enters AND exits (entry + exit wound present)
Penetrating wound - bullet enters and is retained (entry wound only)
Avulsive/Tangential wound - bullet grazes the surface without full penetration

PART 2: INJURIES FROM GUNSHOT TO THE FRONT OF THE CHEST

Anatomical Zones at Risk - Anterior Chest

Zone	Structures at Risk
Cardiac box (sternal notch to xiphoid, nipple-to-nipple)	Heart, great vessels, trachea, esophagus, thoracic duct
Right hemithorax	Right lung/hilum, liver (if low), IVC
Left hemithorax	Left lung/hilum, heart, descending aorta
Upper anterior chest	Trachea, subclavian vessels, brachial plexus
Thoracoabdominal (below 4th ICS anteriorly)	Diaphragm, liver, spleen, stomach

Critical point: The diaphragm rises to the 4th intercostal space anteriorly during expiration. Wounds at or below the nipple line may injure abdominal viscera. Coincident thoracic penetration occurs in up to 46% of patients with abdominal injuries.

PART 3: MANAGEMENT OF SPECIFIC INJURY PATTERNS

1. Simple Pneumothorax

Mechanism: Air enters pleural space from lung laceration - lung collapses ipsilaterally.

Features: Decreased breath sounds, hyperresonance, reduced chest expansion on affected side.

Classification by volume:

Small: <1/3 lung collapse on CXR
Large: complete lung collapse, no mediastinal shift, no hypotension

Management:

Intercostal drain (chest tube) in 4th-5th ICS, anterior axillary line
Occult PTX (CT-only finding, not on CXR): may be observed carefully if hemodynamically stable and not on positive-pressure ventilation. Failure of observation rate = 6% overall (14% if on PPV). Factors predicting failure: PTX >7 mm, PPV, respiratory distress, hemothorax, progression on serial CXR

2. Tension Pneumothorax

Mechanism: One-way valve effect - air continuously enters pleural space and cannot escape. Collapses ipsilateral lung, shifts mediastinum, compresses SVC/IVC - obstructive shock.

Clinical features (Current Surgical Therapy, 14e):

Air hunger, hypoxia, tachypnea
Hyperresonance + absent breath sounds - ipsilateral
Tracheal deviation away from affected side
Distended neck veins + hypotension + tachycardia
Note: Tracheal deviation may be absent if patient is intubated. Neck veins may be flat with concurrent hypovolaemia

Differentiating from Cardiac Tamponade (both cause JVD + hypotension):

Tamponade: muffled heart sounds, NO tracheal deviation, NO asymmetric breath sounds
Tension PTX: tracheal deviation, hyperresonance, absent breath sounds

Management - clinical emergency, do NOT wait for CXR:

Immediate needle decompression - 14-16G angiocatheter, 2nd ICS midclavicular line (or 5th ICS anterior axillary line in obese patients). Rush of air = confirms diagnosis, converts to simple PTX
Followed immediately by chest tube (intercostal drain) in the "safe triangle" (bounded by: lateral border of pectoralis major anteriorly, latissimus dorsi posteriorly, line perpendicular to nipple inferiorly) - Bailey & Love, 28e

Needle decompression for tension pneumothorax at the 2nd intercostal space midclavicular line

Needle decompression technique for tension pneumothorax - Current Surgical Therapy 14e

3. Open Pneumothorax ("Sucking Chest Wound")

Occurs when a large-caliber gunshot creates a chest wall defect exceeding the laryngeal cross-sectional area, allowing atmospheric air to rush in with each respiratory cycle. Lung collapses rapidly; mediastinal shift and decreased venous return follow. (Current Surgical Therapy, 14e)

Signs: Audible sucking/bubbling at wound site, hypoxia, respiratory failure, hypotension.

Management - sequential steps:

Apply three-sided occlusive dressing (petroleum gauze / Asherman chest seal) - allows air to exit on expiration but prevents entry on inspiration
Place intercostal drain remote from the wound - BEFORE closing the defect, to prevent conversion to tension PTX
Once patient is stable: wound debridement and formal surgical closure in the operating theatre

4. Hemothorax

Blood accumulates in the pleural cavity (capacity up to 3 L). Most common injury from both blunt and penetrating thoracic trauma. The pleural space can act as a significant reservoir - supine CXR may miss accumulations <200 mL (shows only diffuse haziness).

Classification by volume:

Small: <300 mL
Moderate: 300-1500 mL
Massive: >1500 mL - may present with tension physiology

Management (Schwartz's Principles of Surgery, 11e):

>85% of all hemothoraces are definitively managed with chest tube alone (reexpansion of the lung seals the low-pressure pulmonary laceration)
One caveat: even if initial output is 1.5 L, if bleeding stops and lung is re-expanded in a hemodynamically stable patient, non-operative management may still be pursued

Indications for thoracotomy (Schwartz's, Table 7-10):

Indication	Threshold
Initial chest tube output - penetrating	>1000 mL
Initial chest tube output - blunt	>1500 mL
Ongoing chest tube output	>200 mL/hr for 3 consecutive hours (non-coagulopathic)
Caked/retained hemothorax	Despite 2 chest tubes
Great vessel injury	Any
Pericardial tamponade	Any
Oesophageal perforation	Any
Air embolism	Any

Retained hemothorax: Video-assisted thoracoscopic surgery (VATS) is the preferred approach in stable patients; reduces empyema risk

5. Cardiac Tamponade

Mechanism: Penetrating injury to the heart - as little as 50 mL of blood in the non-distensible pericardial sac compresses the heart and obstructs venous return. All patients with penetrating injury to the cardiac box plus shock = cardiac injury until proven otherwise.

Classic Beck's Triad:

Elevated CVP / distended neck veins
Hypotension + tachycardia
Muffled heart sounds

Note: Neck veins may be flat if concurrent haemorrhage elsewhere has lowered CVP.

Diagnosis: eFAST is the most expeditious and reliable tool - shows fluid in pericardial sac. Chest X-ray may show enlarged cardiac shadow.

Management (Bailey & Love, 28e):

Pericardiocentesis has NO role in penetrating cardiac tamponade - clot inside pericardium prevents effective aspiration
Correct treatment is operative:
- Subxiphoid pericardial window - for relatively stable patients (allows drainage and diagnosis)
- Left anterolateral thoracotomy or median sternotomy - for definitive cardiac repair
- Emergency Department Thoracotomy - if patient arrests in the ED

Cardiac wound repair (Schwartz's, 11e):

Atrial injuries: Satinsky vascular clamp for hemorrhage control
Ventricular injuries: digital pressure initially; skin staples for temporary control of LV lacerations; Foley catheter balloon for large stellate lesions (use cautiously - traction enlarges wound)
Definitive repair: running 3-0 polypropylene or interrupted pledgeted 2-0 polypropylene sutures; pledgets especially important for thin-walled right ventricle
Injuries adjacent to coronary arteries: horizontal mattress sutures (running sutures would occlude the coronary artery)
Stellate/friable GSW wounds: surgical adhesive (BioGlue) may be used if edges cannot be fully approximated

Techniques for repair of cardiac wounds - Satinsky clamp for atrial injuries, interrupted pledgeted sutures for ventricular wounds, skin staples for temporary control

Cardiac wound repair techniques - Schwartz's Principles of Surgery 11e

6. Emergency Department Resuscitative Thoracotomy (EDRT)

Indicated for patients who arrive in extremis or arrest from penetrating thoracic injury. Non-compressible thoracic hemorrhage is the number one cause of death in organized trauma centres. (Current Surgical Therapy, 14e)

Goals of EDRT:

Release pericardial tamponade
Direct hemorrhage control
Open cardiac massage
Descending aortic cross-clamping (prioritizes cerebral + coronary perfusion; controls sub-diaphragmatic hemorrhage)
Internal defibrillation

EAST Practice Management Guidelines for EDRT:

Signs of Life in ED	Mechanism	Location	Recommendation
Yes	Penetrating	Thoracic	Strongly YES
No	Penetrating	Thoracic	Conditional yes
Yes	Penetrating	Extrathoracic	Conditional yes
No	Penetrating	Extrathoracic	Conditional yes
Yes	Blunt	Any	Conditional yes
No	Blunt	Any	Conditional NO

Western Trauma Association CPR time limits for EDRT:

Penetrating torso: <15 min prehospital CPR
Penetrating neck: <5 min prehospital CPR
Blunt: <10 min prehospital CPR

Survival rates:

Best outcome (~35%): Single penetrating stab wound to cardiac box + tamponade on FAST + witnessed arrest in ED
GSW to chest: lower survival than stab wounds
Blunt cardiac arrest: near-zero survival if unwitnessed

Technique - Left Anterolateral Thoracotomy:

Patient supine, left arm raised
Incision along 4th-5th ICS (males: along nipple line; females: along inframammary fold)
Enter just above the superior border of the rib (avoids intercostal neurovascular bundle)
Open pericardium longitudinally, anterior to phrenic nerve, evacuate clot
Repair cardiac wound, cross-clamp descending aorta if needed
Extend to "clamshell" (bilateral) if right-sided injury suspected

7. Tracheobronchial Injury

Signs: Air escaping from neck wound, massive air leak after tube thoracostomy, hemoptysis, stridor, subcutaneous emphysema, dysphagia. CXR + chest CT are first-line imaging. (Sabiston, current ed.)

Management:

Pass ETT beyond the injury or into the contralateral mainstem bronchus to maintain ventilation
Primary end-to-end repair with 3-0 PDS, single-layer interrupted sutures; buttress suture line with vascularized tissue (pericardium, intercostal muscle, pleura)
Injuries <1/3 circumference with no major air leak: expectant management
Peripheral bronchial injuries with persistent leak: bronchoscopically directed fibrin glue

8. Pulmonary Parenchymal Injury

Majority managed with tube thoracostomy alone
Pulmonary tractotomy: for central injuries encountered during thoracotomy - GIA-100 stapler inserted into wound track, filleted open, individual vessels and bronchi ligated selectively; avoids formal lobectomy
Peripheral lacerations: stapled wedge resection
Formal lobectomy: only when tractotomy reveals proximal injury
Pneumonectomy: usually fatal (right heart decompensation from acute increase in afterload)
Bronchovenous fistula (air embolism risk): minimized by prompt control of major air leaks

9. Thoracoabdominal Wounds (Below Nipple Line)

Must always exclude diaphragmatic injury in anterior wounds below the 4th ICS
Initial wound may appear thoracic but violate the peritoneum
Diagnosis: laparoscopy (most sensitive for diaphragmatic lacerations, which can be very small)
All diaphragmatic injuries require repair
Must assess for concomitant injury to liver, spleen, stomach

PART 4: ATLS APPROACH - INITIAL RESUSCITATION FRAMEWORK

Primary Survey Priorities (ABCDE)

Priority	Action
A - Airway	Secure airway early; RSI; if cannot intubate - surgical cricothyroidotomy
B - Breathing	Identify and treat: tension PTX, open PTX, massive hemothorax, flail chest
C - Circulation	eFAST for tamponade; 2x large-bore IV; permissive hypotension (target SBP 80-90 mmHg) until surgical hemorrhage control; massive transfusion protocol if needed (1:1:1 pRBC:FFP:platelets)
D - Disability	GCS, pupils
E - Exposure	Full undress; find ALL wounds including exit wounds and thoracoabdominal extension

Key transport principle: In urban settings (trauma centre within 15-25 min), rapid transport takes precedence over extensive field interventions. Hypotensive resuscitation (limited or no resuscitation before operative hemorrhage control) is the current military-derived civilian standard for penetrating torso trauma. Cervical collar and spinal immobilization are unnecessary unless the patient has specific cervical complaints. (Roberts & Hedges; Current Surgical Therapy, 14e)

Sources: Current Surgical Therapy 14e | Schwartz's Principles of Surgery 11e | Bailey and Love's Short Practice of Surgery 28e | Mulholland and Greenfield's Surgery 7e | Sabiston Textbook of Surgery (current ed.)

Approach to aub in reproductive age group

Reading File

This is a broad clinical topic - I'll run three-layer parallel searches now.

Finding Sources

Excellent - found the key sections. Now reading the most comprehensive sources in parallel.

Reading File

Excellent content. Now reading more from Berek & Novak and Sabiston for management details, and getting the PALM-COEIN table and treatment algorithms.

Reading File

Getting more content on management, treatment options, and lab studies.

Reading File

Finding Sources

Now getting the management section with specific drug treatments and the Berek & Novak treatment section.

Reading File

Let me get the Berek & Novak treatment section and more on acute management.

Reading File

I have comprehensive content from multiple authoritative sources. Let me also fetch a relevant diagram image for AUB.

Loading Image

Searching Images

PALM-COEIN classification abnormal uterine bleeding diagram

This diagnostic image is an intraoperative hysteroscopic photograph of the uterine cavity. The visual focus is a well-defined, oval-shaped pedunculated endometrial polyp protruding from the posterior uterine wall. The polyp demonstrates a smooth, glistening surface with a pale pink to white color, interspersed with focal areas of erythema and fine vertical striations across its body. Its morphology is slightly lobulated, and it is attached to the uterine wall by a distinct stalk. The surrounding endometrial tissue appears healthy, smooth, and pink, although there is a slight darkening near the base of the pedicle, likely representing minor blood accumulation. This clinical photograph illustrates a common structural cause of abnormal uterine bleeding (AUB), frequently categorized under the 'Polyp' component of the FIGO PALM-COEIN classification system. Such findings are critical in the diagnostic workup of perimenopausal and postmenopausal women to differentiate benign focal abnormalities from endometrial hyperplasia or malignancy.

A complex pathophysiology diagram illustrating various cellular signaling pathways in the human endometrium, specifically highlighting mechanisms dysregulated in uterine fibroids. The flow begins with extracellular ligands binding to transmembrane receptors and concludes with functional physiological outcomes. Key pathways include: (1) TGF-β/SMAD signaling leading to endometrial remodeling and coagulation; (2) PGF2α/FP and ET-1/ETAR/ETBR signaling involving PLC, IP3, Calmodulin, and PKC cascades, which result in spiral artery vasoconstriction and myometrial constriction; (3) ETBR/VEGFR/PDGFR cross-talk through PI3K/AKT/mTOR and RAS/RAF/MEK/ERK pathways, driving vasodilation (via NO), proliferation, and angiogenesis; and (4) TNFα/TNFR signaling through Caspase cascades (apoptosis) and JNK/AP-1 pathways. Icons with upward arrows next to ligands like TGF-β, PGF2α, and VEGF indicate molecular upregulation typically seen in the presence of uterine fibroids. This educational diagram is targeted at an advanced level, illustrating how ligand-receptor interactions contribute to heavy menstrual bleeding and abnormal uterine vascular architecture.

An educational comparison diagram illustrating the differences between normal and abnormal endometrium (specifically endometriosis). The top section displays two anatomical illustrations of a mammal uterus. The 'Normal endometrium' shows a smooth, uniform uterine cavity with an open, Y-shaped internal structure. The 'Abnormal endometrium diagram' depicts a constricted, triangular uterine cavity with thickened, irregular linings and growths, suggestive of ectopic tissue implantation. The bottom section presents five high-magnification grayscale diagnostic images representing cellular pathology. The normal side shows 'Early secretory cells' and 'Early basement membrane' with visible, organized textures and clear cellular arrangements. In contrast, the abnormal side shows 'Abnormal early secretory cells,' 'Abnormal early epithelial cells,' and 'Abnormal early basement membrane,' which exhibit significantly darker, less defined clusters and disrupted structural integrity. This diagram serves as a visual guide to the gross anatomical and microscopic cellular changes associated with endometrial pathology.

I now have comprehensive content from all the key sources. Here is the complete, well-structured answer.

Approach to Abnormal Uterine Bleeding (AUB) in the Reproductive Age Group

1. Definition and Terminology

Abnormal uterine bleeding (AUB) is defined as bleeding that is abnormal in regularity, volume, frequency, or duration, present for at least 6 months, occurring in non-pregnant women of reproductive age. (FIGO Terminology, Tintinalli's EM)

Normal Menstrual Parameters (FIGO)

Parameter	Normal Range
Cycle frequency	24-38 days
Cycle regularity	± <7-9 days variation
Duration of flow	4-8 days (mean 4.7 days)
Volume of blood loss	<80 mL per cycle (mean 35 mL)

Important: The term "dysfunctional uterine bleeding (DUB)" is obsolete and should no longer be used. AUB with the PALM-COEIN classification has replaced all previous imprecise terms (menorrhagia, metrorrhagia, menometrorrhagia). - Berek & Novak's Gynecology

Heavy menstrual bleeding (HMB) - replaces "menorrhagia" - is defined as excessive menstrual bleeding that interferes with a woman's physical, emotional, social, and quality of life, regardless of exact duration or timing (patient-defined).

2. PALM-COEIN Classification (FIGO 2011)

The FIGO Working Group on Menstrual Disorders established this in 2011 to systematize causes of AUB in non-gravid reproductive-age women.

PALM  = Structural causes (diagnosed by imaging or histology)
COEIN = Non-structural/medical causes

PALM - Structural

Cause	Code	Key Features
Polyp	AUB-P	Endometrial/endocervical epithelial proliferations; usually benign; most common cause of intermenstrual bleeding in women >35 years; up to 5% malignant transformation
Adenomyosis	AUB-A	Endometrial glands within myometrium; presents with heavy, painful periods; enlarged "boggy" uterus
Leiomyoma	AUB-L	Most common benign gynecologic tumor (~70% of women by age 50); classified by location (Type 0-8 per FIGO); submucosal types (0, 1, 2) cause most bleeding
- Submucosal	AUB-LSM	Most symptomatically significant for bleeding
- Other (intramural/subserosal)	AUB-LO	Less directly related to bleeding
Malignancy & hyperplasia	AUB-M	Endometrial hyperplasia (simple/complex, with/without atypia); endometrial carcinoma; always rule out in at-risk women

COEIN - Non-Structural

Cause	Code	Key Features
Coagulopathy	AUB-C	Up to 20% of women with HMB have an underlying coagulopathy; Von Willebrand disease is the most common (up to 13% of AUB cases); often presents since menarche
Ovulatory dysfunction	AUB-O	Includes anovulation (PCOS, hypothalamic dysfunction, hyperprolactinemia, thyroid disorders, perimenopause); most common cause in reproductive years
Endometrial	AUB-E	Primary endometrial disorder - defective local hemostasis, altered prostaglandin balance, impaired endometrial repair; diagnosis of exclusion
Iatrogenic	AUB-I	Medications - anticoagulants, hormonal contraceptives (breakthrough bleeding), intrauterine devices, tamoxifen, antipsychotics (via hyperprolactinemia)
Not yet classified	AUB-N	AV malformations, myometrial hypertrophy, rare/poorly understood causes

Hysteroscopic view of an endometrial polyp - a common structural cause of AUB (AUB-P) showing a smooth, pedunculated lesion attached to the posterior uterine wall

Hysteroscopic appearance of an endometrial polyp - a common AUB-P cause

3. Causes by Age in Reproductive Group

Sub-group	Most Likely Causes
Adolescents (13-19 yr)	Anovulation (HPO axis immaturity), coagulopathy (VWD), PCOS, pregnancy, exogenous hormones
Young adults (20-35 yr)	Pregnancy-related (most common), anovulation (PCOS), polyps, leiomyoma, iatrogenic
Mid-reproductive (35-45 yr)	Structural causes rise (fibroids, polyps, adenomyosis), PCOS, endometrial hyperplasia, perimenopause begins

Pregnancy-related complications are the most common cause of AUB during the reproductive years overall.

4. Approach: History

A systematic history should establish:

Bleeding characteristics:

Cycle length, regularity, duration, volume (flooding, clots, pad/tampon count)
Intermenstrual bleeding, postcoital bleeding
Duration of abnormal pattern (acute vs. chronic AUB)

Menstrual history: Age at menarche; history of heavy periods since menarche (suggests coagulopathy)

Obstetric history: Gravidity, parity; prior cesarean section (scar defect/niche - cause of AUB-N)

Associated symptoms:

Pelvic pain/dysmenorrhea (adenomyosis, endometriosis)
Pressure symptoms (large fibroids)
Signs of androgen excess: acne, hirsutism (PCOS)
Galactorrhea (hyperprolactinemia)
Weight change, cold intolerance (thyroid)
Easy bruising, epistaxis, family history of bleeding (coagulopathy)

Medications: Anticoagulants, hormonal contraceptives, antipsychotics, tamoxifen

Risk factors for endometrial malignancy: Obesity, diabetes, nulliparity, anovulation, PCOS, family history of Lynch syndrome

Sexual history: Risk factors for STIs (Chlamydia linked to endometrial inflammation and AUB); unprotected intercourse (pregnancy must be excluded)

5. Physical Examination

General: Signs of anaemia (pallor, tachycardia), obesity, acanthosis nigricans, hirsutism, acne (PCOS)

Thyroid: Nodules, enlargement

Skin: Petechiae, ecchymosis (coagulopathy)

Abdominal: Uterine or pelvic mass

Pelvic examination:

Speculum: Cervical lesions, polyps protruding through cervical os, signs of infection, source of bleeding (confirm it is uterine)
Bimanual: Uterine size, shape, regularity, tenderness (enlarged/irregular = fibroids; enlarged, boggy = adenomyosis); adnexal masses

6. Investigations

Essential for All

Investigation	Purpose
Urine/serum βhCG	First step - exclude pregnancy in all reproductive-age women
CBC + platelets	Assess anaemia and thrombocytopenia
TSH	Thyroid dysfunction (hypothyroidism associated with AUB-O)
Pelvic ultrasound (TVUS preferred)	Best initial imaging - uterine contour, fibroid location/size, endometrial thickness, adnexa

Selective / Based on Clinical Assessment

Investigation	Indication
Prolactin	Irregular cycles, galactorrhea, suspected hyperprolactinemia
Coagulation screen (PT, aPTT, platelet function, VWF antigen + activity, Factor VIII, fibrinogen)	Heavy bleeding since menarche; family history of coagulopathy; patient on anticoagulants; signs of systemic bleeding - done in collaboration with haematologist
Androgen profile (testosterone, DHEAS), fasting glucose, lipids	Clinical features of PCOS
STI screen (Chlamydia, gonorrhoea)	Risk factors for STI or signs of cervicitis
Cervical cytology (Pap smear)	If not up to date
Sonohysterography (SIS)	Better delineation of intracavitary lesions (polyps, submucosal fibroids) than standard TVUS
Hysteroscopy	Gold standard for intracavitary pathology; diagnostic and therapeutic
MRI pelvis	Not first-line; useful for adenomyosis, mapping leiomyoma location/depth pre-operatively, staging endometrial cancer

Endometrial Sampling (Biopsy)

Mandatory indications for endometrial biopsy (Sabiston; Berek & Novak):

Age ≥45 years with AUB (including intermenstrual bleeding)
Any age with:
- Obesity (unopposed oestrogen exposure)
- Chronic anovulation / PCOS
- AUB refractory to medical management
- Persistent AUB despite treatment
- Elevated familial cancer risk (Lynch syndrome)

Endometrial biopsy (Pipelle) has largely replaced D&C as the office procedure of choice. Hysteroscopy + directed biopsy is the gold standard when focal lesion is suspected or office biopsy is unsatisfactory.

Transvaginal ultrasound showing thickened endometrium - an indication for endometrial biopsy in evaluating AUB

TVUS showing thickened endometrium - an important finding in AUB evaluation - Rosen's Emergency Medicine

7. Management

Step 1: Assess Haemodynamic Stability

Acute/heavy AUB with haemodynamic instability:

IV access, fluids, blood products (resuscitation)
Urgent gynaecology consultation
Consider urgent surgical options: D&C, uterine artery embolization (UAE), endometrial ablation, hysterectomy

Step 2: Medical Management (First-line for most)

In most cases, medical therapy should be attempted before surgical management. (Berek & Novak)

A. Hormonal Therapies

Agent	Use	Dose/Notes
Combined oral contraceptive pills (COCPs)	AUB-O (anovulatory); AUB-E; cycle regulation; reduce flow 35-68%	Standard low-dose monophasic pill; contraindicated if thromboembolic history, active smoking >35 yr, breast cancer, liver disease
Progestins (oral)	When oestrogen contraindicated; anovulatory AUB	Medroxyprogesterone acetate 5-10 mg days 15-26 of cycle; OR norethindrone 5 mg TDS x 1 week for acute heavy bleeding; 21-day regimen reduces flow but less acceptable than LNG-IUS
Levonorgestrel-releasing IUS (LNG-IUS)	Treatment of choice for HMB long-term; comparable to hysterectomy for quality of life; should be offered before hysterectomy	52 mg LNG-IUS (Mirena); reduces flow up to 90%; also provides contraception
Depot medroxyprogesterone acetate (DMPA)	Progestin-only option; causes amenorrhoea over time	Irregular breakthrough bleeding initially (counsel patients); 150 mg IM every 3 months
GnRH agonists	Short-term (max 6 months); severe HMB; pre-operative downsizing of fibroids	Leuprolide, goserelin; induce hypo-oestrogenic state; add-back therapy needed if >3-6 months
Conjugated equine oestrogen (IV)	Acute heavy bleeding emergency management	25 mg IV q4-6h; stops acute bleeding by stimulating endometrial growth; always follow with progestin to avoid hyperplasia

B. Non-Hormonal Therapies

Agent	Use	Dose/Notes
Tranexamic acid (antifibrinolytic)	HMB - non-hormonal first choice; FDA-approved 2008	Oral: 1.3 g q8h x 5 days (during menstruation); IV: 10 mg/kg, max 600 mg for acute bleeding; more effective than NSAIDs for HMB
NSAIDs (ibuprofen, mefenamic acid)	HMB + dysmenorrhoea; reduces flow 30-50%	Less effective than tranexamic acid, danazol, or LNG-IUS; avoid in coagulopathy/platelet dysfunction
Antibiotics	AUB-I with confirmed STI/endometritis	Directed by culture/sensitivity

Treatment Efficacy Hierarchy for HMB (Berek & Novak):

LNG-IUS ≈ Danazol > Tranexamic acid > NSAIDs / OCP

Step 3: Management by Specific Cause

Cause	Specific Management
AUB-P (Polyp)	Hysteroscopic polypectomy (definitive); watchful waiting for small asymptomatic polyps
AUB-A (Adenomyosis)	LNG-IUS (first-line medical); GnRH agonists; definitive treatment = hysterectomy
AUB-L (Leiomyoma)	Submucosal (Type 0-2): hysteroscopic myomectomy; Intramural/subserosal with symptoms: myomectomy (preserves fertility), UAE, hysterectomy; medical: GnRH agonists (pre-op downsizing), ulipristal acetate
AUB-M (Malignancy/Hyperplasia)	Hyperplasia without atypia: progestin therapy + surveillance; Atypical hyperplasia/EIN: hysterectomy (high risk of concurrent or progression to cancer); Endometrial cancer: staging hysterectomy + BSO ± lymphadenectomy
AUB-O (Ovulatory dysfunction)	Treat underlying cause (PCOS - metformin, weight loss, OCP; thyroid - replace; hyperprolactinemia - dopamine agonist); OCP or cyclic progestins for cycle regulation
AUB-C (Coagulopathy)	Manage with haematologist; tranexamic acid, DDAVP for VWD; avoid NSAIDs; LNG-IUS effective; hormonal therapy to suppress menses
AUB-I (Iatrogenic)	Modify offending medication; manage breakthrough bleeding with short courses of oestrogen or NSAIDs; counsel about expected bleeding pattern with progestin-only methods

Step 4: Surgical Options

Indicated when medical therapy fails, patient desires definitive treatment, or has no desire for future fertility:

Procedure	Indication
Endometrial ablation	AUB-O/E without structural cause; no desire for future fertility; effective and cost-efficient alternative to hysterectomy; rates of repeat ablation and eventual hysterectomy increase over time
Hysteroscopic polypectomy/myomectomy	AUB-P; AUB-L (submucosal)
Abdominal/laparoscopic myomectomy	Symptomatic fibroids, fertility desired
Uterine artery embolization (UAE)	Fibroids; alternative to surgery; preserves uterus
Hysterectomy	Definitive cure for all causes; adenomyosis (only cure); failed medical therapy; malignancy; patient preference

8. Special Considerations in Reproductive Age

Pregnancy must always be excluded first - ectopic pregnancy and miscarriage are the leading causes of AUB in reproductive-age women overall.

PCOS is the most common endocrine cause of chronic anovulatory AUB (AUB-O) in reproductive age. It is associated with insulin resistance, obesity, and long-term risk of endometrial hyperplasia from chronic unopposed oestrogen - these women need progestin protection of the endometrium.

Coagulopathy screening is warranted when:

Heavy bleeding present since menarche
Family history of bleeding disorder
Signs of bleeding from multiple sites
Failure of routine medical management

Endometrial cancer risk in reproductive age women is increased by: obesity, diabetes, nulliparity, chronic anovulation, PCOS, Lynch syndrome. These women need earlier endometrial sampling.

Contraception considerations: When a woman with AUB also needs contraception, the LNG-IUS is the ideal single intervention (treats HMB + provides highly effective contraception). The copper IUD is contraindicated as it worsens bleeding.

9. Summary Algorithm

AUB in Reproductive Age Woman
            ↓
1. EXCLUDE PREGNANCY (βhCG) ← Always first step
            ↓
2. Haemodynamic assessment
   - Unstable → Resuscitate + urgent gynaecology
   - Stable → Systematic workup
            ↓
3. History + Examination
   → Characterise bleeding pattern
   → Risk stratify for malignancy
            ↓
4. Investigations
   CBC, TSH, prolactin, TVUS (± SIS)
   Coag screen (if indicated)
   Endometrial biopsy (if age ≥45 or risk factors)
            ↓
5. PALM-COEIN classification
   Structural (PALM) → targeted surgical/interventional Rx
   Non-structural (COEIN) → medical Rx first
            ↓
6. Medical Management (first-line)
   • LNG-IUS - gold standard for HMB (long-term)
   • OCP - anovulatory AUB, cycle regulation
   • Tranexamic acid - non-hormonal HMB
   • Progestins - oestrogen contraindicated
   • IV conjugated oestrogen - acute emergency
            ↓
7. If medical management fails / no fertility desire
   Endometrial ablation → Hysterectomy

Sources: Berek & Novak's Gynecology; Sabiston Textbook of Surgery (current ed.); Rosen's Emergency Medicine; Tintinalli's Emergency Medicine, 9e

Approach to aub in reproductive age group

The detailed answer to this question was already provided in my previous response above. Here is the complete structured summary for your reference:

Approach to AUB in the Reproductive Age Group

1. Definition & Terminology

AUB = bleeding abnormal in regularity, volume, frequency, or duration in non-pregnant women, present ≥6 months.

Normal menstrual parameters (FIGO):

Cycle frequency: 24-38 days
Duration: 4-8 days
Blood loss: <80 mL/cycle (mean 35 mL)

The term "dysfunctional uterine bleeding (DUB)" is obsolete. Heavy menstrual bleeding (HMB) replaces "menorrhagia." - Berek & Novak's Gynecology

2. PALM-COEIN Classification (FIGO 2011)

Established by the FIGO Working Group on Menstrual Disorders to classify causes of AUB in non-gravid reproductive-age women.

PALM - Structural Causes (diagnosed by imaging or histology)

Letter	Cause	Code	Key Features
P	Polyp	AUB-P	Endometrial/endocervical proliferations; usually benign; up to 5% malignant transformation; causes intermenstrual bleeding in women >35 yr
A	Adenomyosis	AUB-A	Endometrial glands within myometrium; heavy, painful periods; boggy uterus
L	Leiomyoma	AUB-L	Most common benign gynecologic tumor (~70% by age 50); submucosal types (Type 0, 1, 2) cause most bleeding
M	Malignancy & Hyperplasia	AUB-M	Endometrial hyperplasia (with/without atypia); endometrial carcinoma - must always be excluded

COEIN - Non-Structural/Medical Causes

Letter	Cause	Code	Key Features
C	Coagulopathy	AUB-C	Up to 20% of HMB have underlying coagulopathy; Von Willebrand disease most common (up to 13%); often presents since menarche
O	Ovulatory Dysfunction	AUB-O	PCOS (most common), hypothalamic dysfunction, hyperprolactinemia, thyroid disorders, perimenopause
E	Endometrial	AUB-E	Primary endometrial disorder - defective local haemostasis, altered prostaglandins; diagnosis of exclusion
I	Iatrogenic	AUB-I	Anticoagulants, hormonal contraceptives (breakthrough bleeding), IUDs, tamoxifen, antipsychotics
N	Not yet classified	AUB-N	AV malformations, myometrial hypertrophy, rare causes

3. Causes by Age - Reproductive Group

Sub-group	Most Likely Causes
Adolescents (13-19 yr)	Anovulation (HPO axis immaturity), coagulopathy (VWD), PCOS, pregnancy
Young adults (20-35 yr)	Pregnancy-related (most common overall), anovulation/PCOS, polyps, fibroids, iatrogenic
Mid-reproductive (35-45 yr)	Structural causes (fibroids, polyps, adenomyosis), endometrial hyperplasia, perimenopause, malignancy risk rises

4. History

Bleeding pattern:

Frequency, regularity, duration, volume (pad count, clots, flooding)
Intermenstrual bleeding, postcoital bleeding
Acute vs. chronic AUB

Key points to elicit:

Heavy periods since menarche → coagulopathy (VWD)
Irregular cycles + obesity + hirsutism → PCOS (AUB-O)
Pelvic pain/dysmenorrhea → adenomyosis or endometriosis
Pressure symptoms → large fibroids
Galactorrhea + irregular cycles → hyperprolactinemia
Weight change, cold intolerance → thyroid
Easy bruising, epistaxis, family history of bleeding → coagulopathy
Medication history: anticoagulants, COC, progestins, antipsychotics, tamoxifen
Prior cesarean section → scar defect/niche (AUB-N)
Risk factors for endometrial malignancy: obesity, diabetes, nulliparity, PCOS, family history (Lynch syndrome)
Sexual history: STI risk (Chlamydia causes endometrial inflammation → AUB)

5. Physical Examination

System	Findings to Look For
General	Pallor, tachycardia (anaemia/haemodynamic compromise)
Body habitus	Obesity, acanthosis nigricans, acne, hirsutism → PCOS
Thyroid	Nodules, goitre
Skin	Petechiae, ecchymosis → coagulopathy
Abdomen	Uterine/pelvic mass
Speculum	Cervical lesion, polyp protruding through os, signs of infection, confirm uterine source
Bimanual	Uterine size/regularity/tenderness (irregular/firm = fibroids; enlarged/boggy = adenomyosis); adnexal masses

6. Investigations

Mandatory in All

Test	Purpose
Urine/serum βhCG	Always first - exclude pregnancy
CBC + platelets	Anaemia, thrombocytopenia
TSH	Thyroid dysfunction
Pelvic ultrasound (TVUS preferred)	Uterine contour, endometrial thickness, fibroid mapping, ovaries

Selective (Guided by History/Examination)

Test	Indication
Prolactin	Irregular cycles, galactorrhea
Coagulation screen (PT, aPTT, VWF antigen + activity, Factor VIII, fibrinogen, platelet function)	HMB since menarche; family history; systemic bleeding signs; in collaboration with haematologist
Androgen profile (testosterone, DHEAS), fasting glucose	PCOS features
STI screen (Chlamydia, gonorrhoea)	Risk factors or signs of cervicitis
Cervical cytology	If not up to date
Sonohysterography (SIS)	Better delineation of polyps, submucosal fibroids than standard TVUS
Hysteroscopy	Gold standard for intracavitary pathology - diagnostic and therapeutic
MRI pelvis	Not first-line; for adenomyosis, fibroid mapping pre-operatively, endometrial cancer staging, adnexal pathology

Endometrial Biopsy - Indications

Mandatory in the following (Sabiston; Berek & Novak):

Age ≥45 years with AUB (including intermenstrual bleeding)
Any age with:
- Obesity (chronic anovulation/unopposed oestrogen)
- AUB refractory to medical management
- Persistent AUB despite treatment
- Chronic anovulation / PCOS
- Elevated familial cancer risk (Lynch syndrome)

Pipelle endometrial biopsy has largely replaced D&C as the office procedure of choice. Hysteroscopy + directed biopsy is the gold standard when a focal lesion is suspected or office biopsy yields inadequate tissue.

7. Management

Step 1: Haemodynamic Assessment

Acute heavy AUB + haemodynamic instability:

IV access, resuscitation (fluids, blood products)
Urgent gynaecology consultation
Surgical options: D&C, UAE, endometrial ablation, hysterectomy

Step 2: Medical Management (First-line for most)

Medical therapy should be attempted before surgical management in most cases. - Berek & Novak

Hormonal Therapies

Agent	Indication	Dose/Notes
LNG-IUS (levonorgestrel intrauterine system)	Gold standard for HMB (chronic); AUB-O, AUB-E, AUB-A	52 mg (Mirena); reduces flow up to 90%; comparable to hysterectomy for QoL; should be offered before hysterectomy; also provides contraception
Combined OCP	AUB-O (anovulatory); cycle regulation; reduces flow 35-68%	Low-dose monophasic pill; contraindicated if thromboembolism, smoking >35 yr, breast cancer, liver disease
Progestins (oral)	Oestrogen contraindicated; anovulatory AUB	MPA 5-10 mg days 15-26 of cycle (luteal phase); norethindrone 5 mg TDS x 1 week for acute heavy bleeding; 21-day regimen more effective than luteal phase only
DMPA	Progestin-only option; causes amenorrhoea over time	150 mg IM every 3 months; counsel about initial irregular bleeding
GnRH agonists	Short-term (max 6 months); severe HMB; pre-operative fibroid downsizing	Leuprolide, goserelin; add-back therapy if >3-6 months
IV conjugated equine oestrogen	Acute emergency bleeding	25 mg IV q4-6h; stops acute bleeding; always follow with progestin to prevent hyperplasia

Non-Hormonal Therapies

Agent	Indication	Dose/Notes
Tranexamic acid (antifibrinolytic)	HMB - non-hormonal first choice; FDA-approved 2008	Oral: 1.3 g q8h x 5 days during menses; IV: 10 mg/kg max 600 mg for acute bleeding; more effective than NSAIDs
NSAIDs (ibuprofen, mefenamic acid)	HMB + dysmenorrhoea; reduces flow 30-50%	Less effective than tranexamic acid, danazol, or LNG-IUS; avoid in coagulopathy/platelet dysfunction
Antibiotics	Confirmed STI/endometritis	Directed by culture

Efficacy hierarchy for HMB (Berek & Novak):

LNG-IUS ≈ Danazol > Tranexamic acid > NSAIDs / OCP

Step 3: Cause-Specific Management

Cause	Targeted Treatment
AUB-P	Hysteroscopic polypectomy (definitive); watchful waiting for small asymptomatic polyps
AUB-A	LNG-IUS (first-line medical); GnRH agonists; definitive = hysterectomy (only cure)
AUB-L (submucosal)	Hysteroscopic myomectomy; medical: GnRH agonists pre-op
AUB-L (intramural/subserosal)	Myomectomy (fertility desired); UAE; hysterectomy (definitive)
AUB-M (Hyperplasia, no atypia)	Progestin therapy + surveillance endometrial biopsy
AUB-M (Atypical hyperplasia/EIN)	Hysterectomy (high risk of concurrent or progressing cancer)
AUB-M (Endometrial cancer)	Staging hysterectomy + BSO ± lymphadenectomy
AUB-O (PCOS)	Weight loss, metformin, OCP for cycle regulation; progestin for endometrial protection
AUB-O (Thyroid)	Thyroid replacement/treatment
AUB-O (Hyperprolactinaemia)	Dopamine agonist (cabergoline/bromocriptine)
AUB-C (Coagulopathy)	Haematology co-management; tranexamic acid; DDAVP for VWD; LNG-IUS; hormonal suppression of menses; avoid NSAIDs
AUB-I (Iatrogenic)	Modify offending drug; breakthrough bleeding with progestins → short course oestrogen or NSAIDs

Step 4: Surgical Options (When Medical Therapy Fails / No Fertility Desire)

Procedure	Indication
Endometrial ablation	AUB-O/E, no structural cause, no future fertility desired; effective alternative to hysterectomy; rates of repeat ablation/hysterectomy increase over time
Hysteroscopic polypectomy	AUB-P (definitive)
Hysteroscopic myomectomy	Submucosal fibroids (Type 0-2)
Laparoscopic/open myomectomy	Intramural/subserosal fibroids, fertility desired
Uterine artery embolization (UAE)	Fibroids; uterus-preserving; alternative to surgery
Hysterectomy	Definitive for all causes; only cure for adenomyosis; failed medical therapy; malignancy/atypical hyperplasia; patient preference

8. Special Considerations

Pregnancy exclusion is always the first step - ectopic pregnancy and miscarriage are the leading causes of AUB in reproductive-age women overall
PCOS is the most common endocrine cause of chronic anovulatory AUB; these women need progestin protection of the endometrium to prevent hyperplasia from chronic unopposed oestrogen
Coagulopathy screening is warranted when HMB has been present since menarche, there is a family history, or there are signs of bleeding at multiple sites
LNG-IUS is ideal when a woman with AUB also needs contraception (treats HMB + highly effective contraception in a single device) - copper IUD is contraindicated as it worsens bleeding
Endometrial malignancy in the reproductive age group is rare but must be actively excluded in high-risk women (obese, diabetic, nulliparous, chronic anovulation, Lynch syndrome)

9. Summary Algorithm

AUB in Reproductive Age
         ↓
1. EXCLUDE PREGNANCY (βhCG) ← ALWAYS FIRST
         ↓
2. Haemodynamic assessment
   Unstable → Resuscitate + urgent gynaecology
   Stable → Systematic workup
         ↓
3. History + Examination
   Characterise bleeding | Risk stratify for malignancy
         ↓
4. Investigations
   CBC, TSH, Prolactin, TVUS
   Coag screen if indicated
   Endometrial biopsy if age ≥45 or risk factors
         ↓
5. PALM-COEIN Classification
   Structural (PALM) → targeted surgical/interventional Rx
   Non-structural (COEIN) → medical Rx first
         ↓
6. Medical Management (first-line)
   LNG-IUS (gold standard for chronic HMB)
   OCP (anovulatory AUB, cycle regulation)
   Tranexamic acid (non-hormonal HMB)
   Progestins (oestrogen contraindicated)
   IV conjugated oestrogen (acute emergency only)
         ↓
7. Medical failure / No fertility desire
   Endometrial ablation → Hysterectomy

Sources: Berek & Novak's Gynecology; Sabiston Textbook of Surgery; Rosen's Emergency Medicine; Tintinalli's Emergency Medicine 9e

This is a shared conversation. Sign in to Orris to start your own chat.